PA Home | Positively Aware en Español | HIV Drug Guide | HIV Services Directory | Subscribe | Advertise | Editorial Policy | Archives
The Journal of Test Positive Aware Network


Jan/Feb Issue Home

Download PDF Version

Download Drug Chart PDF

Departments

Articles

 
Positively Aware January/February 2008
Side Effects Chart
Nucleoside Reverse Transcriptase Inhibitors (also called nucleoside analogs, NRTIs, or nukes)
Potential class side effects Pancreatitis (inflammation of the pancreas), enlarged, fatty liver, and lactic acidosis.
Combivir (Retrovir and Epivir)
See Epivir and Retrovir.
Emtriva (emtricitabine, FTC)
A very tolerable drug, but potential side effects include headache, diarrhea, nausea and rash. Darkening of the skin on the palms and the soles of the feet.
Epivir (lamivudine, 3TC)
A very tolerable drug, but potential side effects include headache, nausea, diarrhea, fatigue, hair loss, insomnia, malaise (general ill feeling), nasal symptoms, cough, peripheral neuropathy, low white blood cells and anemia. Children note pancreatitis (inflammation of the pancreas).
Epzicom (Epivir and Ziagen)
See Epivir and Ziagen.
Retrovir
(zidovudine or ZDV, AZT)
Do not take with Combivir or Trizivir, since zidovudine is already in these medications. Amphotericin B, Benemid, Biaxin, Cytovene, dapsone, Depakote, Dilantin, doxorubicin, flucytosine, ganciclovir, hydroxyurea, interferon-alpha, Mycobutin, pentamidine, Rebetol, ribavirin, rifampin, sulfadiazine, Valcyte, Vitrasert, and Zerit.
Trizivir (Epivir, Retrovir, and Ziagen)
Headaches, fever, chills, muscle soreness, fatigue, nausea, fingernail discoloration, anemia, and neutropenia.
Truvada (Viread and Emtriva)
See Viread and Emtriva.
Videx & Videx EC
(didanosine, ddI)
Peripheral neuropathy, upset stomach, diarrhea, headache, pancreatitis (inflammation of the pancreas), eye changes and optic neuritis, increased uric acid levels, and insomnia.
Viread (tenofovir disoproxil fumarate, TDF)
Overall fairly well tolerated; however, individuals may experience the following: nausea, headache, rash, diarrhea, vomiting, asthenia (fatigue, weakness), flatulence (gas), abdominal distension/pain, loss of appetite, kidney toxicities, bone changes, pancreatitis (inflammation of the pancreas), and low blood phosphate.
Zerit (stavudine, d4T)
Peripheral neuropathy, facial wasting, mitochondrial toxicities, headache, chills/fever, malaise, insomnia, anxiety, depression, rash, upset stomach, diarrhea, abdominal pain, and blood lipid increases. Children note peripheral neuropathy.
Ziagen (abacavir sulfate, ABC) Hypersensitivity reaction, nausea, vomiting, diarrhea, fatigue, headache, fever, rash, and loss of appetite.
Non-Nucleoside Reverse Transcriptase Inhibitors (also called non-nucleoside analogs, NNRTIs, or non-nukes)
Potential class side effects Rash.
Intelence (etravirine, TMC-125)
Rash, diarrhea, nausea, and headache.

Rescriptor (delavirdine, DLV)

Headache, nausea, vomiting, diarrhea, fatigue, elevated liver enzymes, itchy skin or rash.
Sustiva (efavirenz)
Central nervous system (CNS) and psychiatric symptoms. Rash, nausea, vomiting, diarrhea, fever, insomnia and increased triglyercides, good cholesterol (HDL) and liver enzymes. False positive tests for use of marijuana. Birth defects.
Viramune (nevirapine)
Headache, nausea, vomiting, fever, rash, Stevens-Johnson syndrome, and drug-induced hepatitis.
Dual-class Fixed Dose Combination
Atripla (Sustiva/Truvada)
See Sustiva and Truvada (Emtriva and Viread). Atripla dose cannot be adjusted for people with kidney problems. Nausea, diarrhea, rash, Immune Reconstitution Inflammatory Syndrome (IRIS).
Protease inhibitors (PIs)
Potential class side effects
Increased levels of cholesterol and triglycerides (except possibly unboosted Reyataz), lipodystrophy, onset of new cases or worsening of diabetes, Immune Reconstitution Inflammatory Syndrome (IRIS), and increased bleeding in hemophiliacs.
Aptivus (tipranavir)

Gastrointestinal-related—mild diarrhea, nausea, vomiting, abdominal pain, and fatigue. Headaches, dry mouth, rash (including sensitivity to sun), dizziness, hepatotoxicity, and bleeding in the brain. Aptivus has a “sulfa” component, and should be used with caution in patients with allergies to sulfa drugs. Also see Norvir.
Crixivan (indinavir sulfate)
Headache, fatigue or weakness, malaise, nausea, diarrhea, stomach pains, loss of appetite, yellowing of skin/eyes, changed skin color, dry mouth/sore throat, taste changes, painful urination, indigestion, joint pain, hives, and liver toxicity. Itchy/dry skin, ingrown toenails and hair loss. Kidney stones. Increased bilirubin.
Invirase (saquinavir)
Stomach related—diarrhea, abdominal discomfort, and nausea. Also see Norvir.
Kaletra (lopinavir/ritonavir) Rash, diarrhea, nausea, vomiting, stomach pain, headache, muscle weakness, increased cholesterol and triglycerides, and elevated liver function test. Also see Norvir.
Lexiva (fos-amprenavir calcium) Nausea, rash, diarrhea, headache, vomiting, fatigue, and abdominal pain. Lexiva has a “sulfa” component, and should be used with caution in patients with allergies to sulfa drugs.
Norvir (ritonavir)
Weakness, stomach pain, upset stomach, tingling/numbness around the mouth, hands or feet, loss of appetite, taste disturbance, weight loss, headache, dizziness, pancreatitis, and alcohol intolerance. Liver problems, increased muscle enzymes, and uric acid.
Prezista (darunavir)
Rash, diarrhea, nausea, headache, and common cold. Prezista contains a “sulfa” part to it and should be used cautiously in patients with “sulfa” allergies. See also Norvir.
Reyataz (atazanavir sulfate) Dizziness, lightheadedness, rash, kidney stones, and elevated liver function tests. Elevated levels of unconjugated bilirubin.
Viracept (nelfinavir) Diarrhea, stomach discomfort, nausea, gas, weakness, and rash.
Entry Inhibitors
Fuzeon (enfuvirtide, T-20)
Injection site reactions (ISRs), Immune Reconstitution Inflammatory Syndrome (IRIS), and pneumonia. Allergic reactions are possible.
Selzentry (maraviroc)
Cough, fever, cold, rash, muscle and joint pain, stomach pain, dizziness, liver toxicity, allergic reaction, low blood pressure, diarrhea, edema (swelling), trouble sleeping, urinary problems. Possible increased risk of infections and cancer.
Integrase Inhibitor
Isentress (raltegravir, formerly MK-0518
Diarrhea, nausea, vomiting, headache, fever, abdominal pain, fatigue, weakness, dizziness, and lipodystrophy.

 

This site contains HIV prevention messages that may not be appropriate for all audiences. Since HIV infection is spread primarily through sexual practices or by sharing needles, prevention messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this website.

Este sitio del web contiene mensajes de la prevención del VIH que pueden no ser appropiados para todas las audiencias. Puesto que la infección del VIH es propagada sobre todo con prácticas sexuales o por compartiendo jeringas, los mensajes y los programas de la prevención pueden dirigirse a estos asuntos. Si usted no está buscando tal información o puede ser ofendido por tales materiales, salga por favor de este website.

Opinions expressed in Positively Aware, Positively Aware en Español, or tpan.com are not necessarily those of staff or membership of Test Positive Aware Network (TPAN), its supporters and sponsors, or distributing agencies. Information, resources, and advertising in Positively Aware, Positively Aware en Español, or tpan.com do not constitute endorsement or recommendation of any medical treatment or product.

TPAN recommends that all medical treatments or products be discussed thoroughly and frankly with a licensed and fully HIV-informed medical practitioner, preferably a personal physician.

Although Positively Aware, Positively Aware en Español, and tpan.com take great care to ensure the accuracy of all the information that it presents, Positively Aware, Positively Aware en Español, and tpan.com staff and volunteers, TPAN, or the institutions and personnel who provide us with information cannot be held responsible for any damages, direct or consequential, that arise from use of this material or due to errors contained herein.